Assessment of Clinical Efficacy of Dexamethasone in Patients with Moderate COVID-19 by M. V. Tolochko, I. N. Leyderman, O. A. Khokhunov, V. A. Mazurok, R. E. Rzheutskya

Subjects: Get full text

Successful Treatment of Recurrent Adult-Onset Still’s Disease with Tocilizumab: A Case Report and Literature Review by Zhong X, Xu T, Li T, Luo N, Luo N, Hao P

Subjects: Get full text

Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rh... by Akira Onishi, Masao Tanaka, Takayuki Fujii, Koichi Murata, Kosaku Murakami, Motomu Hashimoto, Ryu Watanabe, Yuji Nozaki, Chisato Ashida, Wataru Yamamoto, Hirotaka Yamada, Sho Sendo, Kosuke Ebina, Hidehiko Makino, Yonsu Son, Yumiko Wada, Kenichiro Hata, Shuichi Matsuda, Akio Morinobu

Subjects: Get full text

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge by Pranay Sinha, Anahita Mostaghim, Catherine G. Bielick, Angela McLaughlin, Davidson H. Hamer, Lee M. Wetzler, Nahid Bhadelia, Maura A. Fagan, Benjamin P. Linas, Sabrina A. Assoumou, Michael H. Ieong, Nina H. Lin, Ellen R. Cooper, Karrine D. Brade, Laura F. White, Tamar F. Barlam, Manish Sagar

Subjects: Get full text

Effectiveness and safety of TNF-α inhibitors and il-6 pathway antagonists for refractory Takayasu arteritis by V. E. Logina, N. M. Bulanov, A. A. Efimova, N. P. Vlasova, K. V. Makarova, P. I. Novikov, S. V. Moiseev

Subjects: Get full text

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6) by E. L. Nasonov, E. Feist

Subjects: Get full text

Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6 by Evgeny L. Nasonov, Azamat M. Satybaldyev, Elvira N. Otteva, Tatiana V. Beketova, Andrey A. Baranov

Subjects: Get full text

Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis by Jin Zhang, Jin Zhang, Xiongxiong Fan, Xiaoyu Zhang, Fengli Jiang, Yiping Wu, Beibei Yang, Xinghuan Li, Dong Liu, Dong Liu

Subjects: Get full text

Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders by T. A. Lisitsyna, D. Yu. Veltishchev, A. M. Lila, E. L. Nasonov

Subjects: Get full text

Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis by Jerin Jose Cherian, Madhavi Eerike, Bhavani Shankara Bagepally, Saibal Das, Saibal Das, Samiran Panda

Subjects: Get full text

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs by Po-Lin Chen, Po-Lin Chen, Po-Lin Chen, Nan-Yao Lee, Nan-Yao Lee, Cong-Tat Cia, Cong-Tat Cia, Wen-Chien Ko, Wen-Chien Ko, Po-Ren Hsueh

Subjects: Get full text

Retrospective Observational Analysis of Tocilizumab Outcomes in COVID-19 Patients at a Tertiary Care Hospital by Vrushali Avinash Aringale, Bharti Daswani, Madeline Fernandes

Subjects: “…Cytokine Storm; Immunosuppressive Drug; Interleukin-6 Inhibitor…”
Get full text

Cutaneous necrotizing vasculitis in a patient with rheumatoid arthritis that developed after COVID-19: description of a clinical case by R. M. Balabanova, L. N. Denisov

Subjects: Get full text

Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review by Ying Wang, Kun Zhu, Rulin Dai, Rui Li, Miao Li, Xin Lv, Qian Yu

Subjects: Get full text

Experience of using the interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis in real-life clinical practice (based on data from Tyumen Regional Rheumatology Cen... by I. M. Patrikeeva, Yu. A. Lushpaeva, N. V. Knaub, E. A. Ustinova, O. A. Belikov, M. B. Dolgikh, T. Yu. Malysheva

Subjects: Get full text

SYSTEMIC VASCULITIS WITH LESION OF LARGE VESSELS AS A CAUSE OF ART ERIAL HYPERT ENSION IN A PATIENT OF YOUNG AGE by D. Yu. Andriyashkina, N. A. Demidova, N. А. Shostak, D. V. Somov, М. A. Laperishvili

Subjects: Get full text

Compassionate Use of Tocilizumab in Patients with Coronavirus Disease 2019 in a Low-resource Country, Pakistan: A Pilot Study by Muhammad Amir, Amir Gafoor, Zafar Iqbal, Shehriyar Ashraf, Salma Zeb

Subjects: “…tocilizumab (interleukin 6 inhibitor)…”
Get full text

Possibility of complex medicamental and endovascular treatment of pulmonary hypertension in Takayasu arteritis with predominant pulmonary arteries’ lesion by T. V. Маrtynuk, A. M. Aleevskaya, V. V. Gramovich, N. M. Danilov, I. Z. Korobkova, U. G. Matchin, L. V. Solodovnikova, T. V. Beketova

Subjects: Get full text

Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of ther... by P. A. Shesternya, A. A. Baranov, I. B. Vinogradova, O. N. Anoshenkova, O. V. Antipova, E. A. Bogdanova, Yu. Yu. Grabovetskaya, E. P. Ilivanova, A. N. Kalyagin, A. A. Blinova, N. A. Lapkina, M. V. Mokrousova, O. B. Nesmeyanova, N. M. Nikitina, N. V. Yudina, E. N. Alekseev, E. L. Nasonov, A. M. Lila

Subjects: Get full text

Difficult-to-treat rheumatoid arthritis: predictors and prevention possibilities (analysis of the Moscow unified register of arthritis data) by E. V. Zhilyaev, G. V. Lukina, E. N. Koltsova, E. I. Schmidt, K. A. Lytkina, I. V. Pozharov

Subjects: Get full text